Greenwich Lifesciences Inc (GLSI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $201.97M
Last updated: Nov 17, 2026 at 4:41 PM ET
Greenwich Lifesciences Inc (GLSI) Stock Chart
Greenwich Lifesciences (GLSI) has a latest price of $18.70 on Nov 17, 2026, 45.2% below its 52-week high of $34.10. Its price rose 124.8% over the past 12 months. The month-end price fell 50.8% over the 5 years through Oct 2026, a compound annual decline of 13.2%.
Price Chart
From Sep 2020 to Oct 2026, its highest month-end close was $44.94 in Jun 2021 and its lowest $3.51 in Oct 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GLSI with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GLSI.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 7.8%, and over 6 months it fell 28.9%. The month-end price rose 108.3% over the 3 years through Oct 2026, a compound annual rate of 27.7%.
| Period | Change |
|---|---|
| 1 month | +22.9% |
| 3 months | +7.8% |
| 6 months | -28.9% |
| 12 months | +124.8% |
| 12 months, with dividends | +124.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +108.3% | +27.7% |
| 5 years | -50.8% | -13.2% |
Price by Year
Its best calendar year was 2025, when the price rose 87.1%, and its weakest was 2022, when it fell 37.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $17.41 | -17.1% |
| 2025 | $21.01 | +87.1% |
| 2024 | $11.23 | +6.7% |
| 2023 | $10.52 | -30.8% |
| 2022 | $15.20 | -37.5% |
| 2021 | $24.33 | -33.3% |
Trading Range
The price is 12.8% above its 50-day average of $16.58 and 10.3% below its 200-day average of $20.84.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $18.70 | |
| 52-week high | $34.10 | -45.2% |
| 52-week low | $7.78 | +140.4% |
| 50-day average | $16.58 | +12.8% |
| 200-day average | $20.84 | -10.3% |
Price Risk
Over 3 years, its largest fall from a peak was 61.9%.
| Measure | Value |
|---|---|
| 1-year beta | 3.12 |
| Largest fall, 1 year | -61.9% |
| Largest fall, 3 years | -61.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GLSI
What is GLSI's 1-year price change?
Greenwich Lifesciences's price rose 124.8% over the past 12 months. With dividends included, the 12-month total return was 124.8%.
What is GLSI's 5-year price change?
Greenwich Lifesciences's month-end price fell 50.8% over the 5 years through Oct 2026, a compound annual decline of 13.2%. These figures leave out dividends.
What is GLSI's 52-week high and low?
Greenwich Lifesciences's 52-week high is $34.10 and its 52-week low is $7.78. Its latest price of $18.70 on Nov 17, 2026 is 45.2% below the high.
What is GLSI's beta?
Greenwich Lifesciences's 1-year beta against the S&P 500 is 3.12, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 61.9%.
Is the GLSI chart free?
Yes. Advanced Charting for GLSI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GLSI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors